39 results
Page 2 of 2
424B5
1wue73 9vpi0gsf6
1 Apr 20
Prospectus supplement for primary offering
5:33pm
8-K
EX-99.1
nwip903
25 Feb 20
Nevro Reports Fourth Quarter and Full Year 2019 Financial Results
4:22pm
PRE 14A
wjy0sloyp5g
29 Mar 19
Preliminary proxy
4:53pm
8-K
EX-99.1
cfcnp1an3udeq5ibgvvn
21 Feb 19
Nevro Reports Fourth Quarter and Full Year 2018 Financial Results
4:17pm
8-K
EX-99.1
yar884oms t7fd
7 May 18
Nevro Reports First Quarter 2018 Financial Results
4:12pm
10-K
mni00dv4pevtd9i268vl
18 Mar 15
Annual report
12:00am
8-K
EX-99.1
z8p7hocx01prs q17
23 Jan 15
Nevro Receives Approvable Letter from U.S. Food and Drug Administration for Senza® Spinal Cord Stimulation System
12:00am
8-K
EX-99.1
82p394bcu4xs2rp
2 Dec 14
Nevro Reports Third Quarter Financial Results
12:00am
424B4
jpvg2e
6 Nov 14
Prospectus supplement with pricing info
12:00am
S-1/A
qn92 g9o5ujtg
10 Oct 14
IPO registration (amended)
12:00am
S-1
q1gf 6swb
3 Oct 14
IPO registration
12:00am
DRS/A
76tog2zm 0rkwpzur7
16 Sep 14
Draft registration statement (amended)
12:00am